Case study: Bartonella and Babesia co-infection in family associated with neurological illnesses
In a new case study, researchers from North Carolina State University found that a family suffering from illnesses that ...
Neurology Advisor1h
Leqembi Monthly IV Maintenance Dosing Approved for Early Alzheimer Disease
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
southcoasttoday7h
New Bedford pastor nearly paralyzed from a rare disease. He's made a miraculous comeback.
Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...
MedPage Today19h
FDA OKs New Wearable Treatment for Parkinson's Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
If your dog’s tongue is hanging out, it might be a health issue: here’s what you should do
A dog’s tongue hanging out can be normal, but persistent exposure may signal health issues. Learn the causes, warning signs, ...
Healio22h
IV edaravone may slow disease-progression milestones in ALS
Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...
MedPage Today20h
Microplastics in the Brain; Amyloid After COVID; Alzheimer's and Extreme Heat
Prehospital hypoxia, hypotension, and hypocarbia each were associated with poor outcomes after traumatic brain injury, ...
Healio17h
FDA approves Onapgo for motor fluctuations in adults with Parkinson’s disease
The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
Magic mirrors to AI dolls, five health tech innovations to watch out for
CES event showcased cutting-edge health tech innovations, including smart diapers, AI-powered glasses, and a walking ...
Shocking study finds human brains have a spoonful of microplastics
Researchers have discovered that microplastics are increasingly accumulating in human brains, surging by 50% in just eight ...
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...
Science Daily14h
All in the eyes: High resolution retinal maps aid disease diagnoses
Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...